Login / Signup

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy.

Jorge E CortesFlorian H HeidelWalter FiedlerB Douglas SmithTadeusz RobakPau MontesinosAnna CandoniBrian LeberMikkael A SekeresDaniel A PollyeaRoxanne FerdinandWeidong Wendy MaThomas O'BrienAshleigh O'ConnellGeoffrey ChanMichael Heuser
Published in: Journal of hematology & oncology (2020)
ClinicalTrials.gov NCT01546038 (March 7, 2012).
Keyphrases
  • acute myeloid leukemia
  • low dose
  • high dose
  • allogeneic hematopoietic stem cell transplantation
  • newly diagnosed
  • mesenchymal stem cells
  • smoking cessation